ISA reports highlights of randomized Phase 2 cancer vaccine trial in head & neck cancer

ISA, in partnership with Erasmus MC, is awarded TKI grant and expands clinical pipeline

Vaccine-Chemo Combo Shows Promise in Treating Advanced, HPV-Associated Cervical Cancer

ISA Pharmaceuticals announces CervISA publication

ISA Pharmaceuticals B.V. receives EUR 20m loan from European Investment Bank